Microarray for hepatitis B virus genotyping and detection of 994 mutations along the genome

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 4207-4215

  Gauthier, Marie ^a   Bonnaud, Bertrand ^b   Arsac, Maud ^b   Lavocat, Fabien ^a   Maisetti, Jérôme ^b   Kay, Alan ^c   Simon, François ^d   Zoulim, Fabien ^c   Vernet, Guy ^a  

^a Lab Pasteur Merieux Connaught   (France)

^b Information Technologies Department   (France)

^c INSERM   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; EMTRICITABINE; ENTECAVIR; FAMCICLOVIR; LAMIVUDINE; TELBIVUDINE; TENOFOVIR;

ARTICLE; CODON; DNA MICROARRAY; DNA POLYMORPHISM; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPADNAVIRIDAE; HEPATITIS B; HEPATITIS B VIRUS; HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS GENE; VIRUS LOAD;

AUTOMATION; GENOME, VIRAL; HEPATITIS B VIRUS; HUMANS; MICROARRAY ANALYSIS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; VIRAL PROTEINS; VIROLOGY;

HEPATITIS B VIRUS;

EID: 78049494010     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00344-10     Document Type: Article

References (38)

1. Arauz-Ruiz, P., H. Norder, B. H. Robertson, and L. O. Magnius. 2002. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol. 83:2059-2073.
2. Brunelle, M. N., A. C. Jacquard, C. Pichoud, D. Durantel, S. Carrouee-Durantel, J. P. Villeneuve, C. Trepo, and F. Zoulim. 2005. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir. Hepatology 41:1391-1398.
3. Brunetto, M. R., M. Giarin, G. Saracco, F. Oliveri, P. Calvo, G. Capra, A. Randone, M. L. Abate, P. Manzini, M. Capalbo, et al. 1993. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 105:845-850.
4. Buti, M., I. Elefsiniotis, R. Jardi, V. Vargas, F. Rodriguez-Frias, M. Schapper, S. Bonovas, and R. Esteban. 2007. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. J. Hepatol. 47:366-372. (Pubitemid 47176160)
5. Cooreman, M. P., G. Leroux-Roels, and W. P. Paulij. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed Sci. 8:237-247.
6. Delaney, W. E. T., and K. Borroto-Esoda. 2008. Therapy of chronic hepatitis B: trends and developments. Curr. Opin. Pharmacol. 8:532-540.
7. European Association for the Study of the Liver. 2009. EASL clinical practice guidelines: management of chronic hepatitis B. J. Hepatol. 50:227-242.
8. Günther, S. 2006. Genetic variation in HBV infection: genotypes and mutants. J. Clin. Virol. 36(Suppl. 1):S3-S11.
9. Hannoun, C., K. Krogsgaard, P. Horal, and M. Lindh. 2002. Genotype mixtures of hepatitis B virus in patients treated with interferon. J. Infect. Dis. 186:752-759.
10. Jardi, R., F. Rodriguez, M. Buti, X. Costa, A. Valdes, H. Allende, M. Schaper, R. Galimany, R. Esteban, and J. Guardia. 2004. Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J. Hepatol. 40:507-514.
11. Kao, J. H., N. H. Wu, P. J. Chen, M. Y. Lai, and D. S. Chen. 2000. Hepatitis B genotypes and the response to interferon therapy. J. Hepatol. 33:998-1002.
12. Kay, A., and F. Zoulim. 2007. Hepatitis B virus genetic variability and evolution. Virus Res. 127:164-176.
13. Kramvis, A., M. Kew, and G. Francois. 2005. Hepatitis B virus genotypes. Vaccine 23:2409-2423.
14. Lacombe, K., V. Massari, P. M. Girard, L. Serfaty, J. Gozlan, G. Pialoux, P. Mialhes, J. M. Molina, C. Lascoux-Combe, D. Wendum, F. Carrat, and F. Zoulim. 2006. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS 20:419-427.
15. Liu, S., H. Zhang, C. Gu, J. Yin, Y. He, J. Xie, and G. Cao. 2009. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J. Natl. Cancer Inst. 101:1066-1082.
16. Locarnini, S. 2003. Hepatitis B viral resistance: mechanisms and diagnosis. J. Hepatol 39(Suppl. 1):S124-S132.
17. Lok, A. S., F. Zoulim, S. Locarnini, A. Bartholomeusz, M. G. Ghany, J. M. Pawlotsky, Y. F. Liaw, M. Mizokami, and C. Kuiken. 2007. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46:254-265.
18. Lok, A. S., F. Zoulim, S. Locarnini, A. Mangia, G. Niro, H. Decraemer, G. Maertens, F. Hulstaert, K. De Vreese, and E. Sablon. 2002. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J. Clin. Microbiol. 40:3729-3734.
19. Lupberger, J., and E. Hildt. 2007. Hepatitis B virus-induced oncogenesis. World J. Gastroenterol. 13:74-81.
20. Nguyen, D. H., L. Ludgate, and J. Hu. 2008. Hepatitis B virus-cell interactions and pathogenesis. J. Cell. Physiol. 216:289-294.
21. Norder, H., A. M. Courouce, P. Coursaget, J. M. Echevarria, S. D. Lee, I. K. Mushahwar, B. H. Robertson, S. Locarnini, and L. O. Magnius. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
22. Ogata, N., R. H. Miller, K. G. Ishak, and R. H. Purcell. 1993. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 194:263-276.
23. Osiowy, C. 2006. Detection of HBsAg mutants. J. Med. Virol. 78(Suppl. 1):S48-S51.
24. Pas, S. D., N. Tran, R. A. de Man, C. Burghoorn-Maas, G. Vernet, and H. G. Niesters. 2008. Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus. J. Clin. Microbiol. 46:1268-1273.
25. Quinlan, A. R., and G. T. Marth. 2007. Primer-site SNPs mask mutations. Nat. Methods 4:192.
26. Sato, S., K. Suzuki, Y. Akahane, K. Akamatsu, K. Akiyama, K. Yunomura, F. Tsuda, T. Tanaka, H. Okamoto, Y. Miyakawa, and M. Mayumi. 1995. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann. Intern. Med. 122:241-248.
27. Shaw, T., A. Bartholomeusz, and S. Locarnini. 2006. HBV drug resistance: mechanisms, detection and interpretation. J. Hepatol. 44:593-606.
28. Sheldon, J., B. Rodes, F. Zoulim, A. Bartholomeusz, and V. Soriano. 2006. Mutations affecting the replication capacity of the hepatitis B virus. J. Viral Hepat. 13:427-434.
29. Simmonds, P., and S. Midgley. 2005. Recombination in the genesis and evolution of hepatitis B virus genotypes. J. Virol. 79:15467-15476. (Pubitemid 43032329)
30. Stephens, M., J. S. Sloan, P. D. Robertson, P. Scheet, and D. A. Nickerson. 2006. Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat. Genet. 38:375-381.
31. Stuyver, L. J., S. A. Locarnini, A. Lok, D. D. Richman, W. F. Carman, J. L. Dienstag, and R. F. Schinazi. 2001. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33:751-757.
32. Sugauchi, F., E. Orito, T. Ichida, H. Kato, H. Sakugawa, S. Kakumu, T. Ishida, A. Chutaputti, C. L. Lai, R. Ueda, Y. Miyakawa, and M. Mizokami. 2002. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J. Virol. 76:5985-5992.
33. Tang, H., N. Oishi, S. Kaneko, and S. Murakami. 2006. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci. 97:977-983.
34. Tran, N., R. Berne, R. Chann, M. Gauthier, D. Martin, M. A. Armand, A. Ollivet, C. G. Teo, S. Ijaz, D. Flichman, M. Brunetto, K. P. Bielawski, C. Pichoud, F. Zoulim, and G. Vernet. 2006. European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes. J. Clin. Microbiol. 44:2792-2800.
35. Vray, M., J. M. Debonne, J. M. Sire, N. Tran, B. Chevalier, J. C. Plantier, F. Fall, G. Vernet, F. Simon, and P. S. Mb. 2006. Molecular epidemiology of hepatitis B virus in Dakar, Senegal. J. Med. Virol. 78:329-334.
36. Weber, B. 2005. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J. Clin. Virol. 32:102-112.
37. Zoulim, F. 2004. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection. Antiviral Res. 64:1-15.
38. Zoulim, F., X. Zhang, C. Pichoud, and C. Trepo. 1996. Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc. J. Hepatol. 24:155-160. (Pubitemid 26059115)